Paper40657643
Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases.
Bi S and 6 others. Front Pharmacol, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases. Papers, record 40657643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40657643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21992896 | Salvianolic acid B suppresses IFN-γ-induced JAK/STAT1 activation in endothelial cells. | Thromb Res | 2011 | https://conductscience.org/library/papers/21992896 | PubMed |
| 2 | 36826049 | Neuroprotective Effects of Geopung-Chunghyuldan Based on Its Salvianolic Acid B Content Using an In Vivo Stroke Model. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/36826049 | PubMed |
| 3 | 25981395 | Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats. | Brain Res Bull | 2015 | https://conductscience.org/library/papers/25981395 | PubMed |
| 4 | 29180227 | Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury. | Brain Res | 2018 | https://conductscience.org/library/papers/29180227 | PubMed |
| 5 | 33994527 | Salvianolic acid B protects against MPP+-induced neuronal injury via repressing oxidative stress and restoring mitochondrial function. | Neuroreport | 2021 | https://conductscience.org/library/papers/33994527 | PubMed |
| 6 | 24780446 | Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways. | Biochem Pharmacol | 2014 | https://conductscience.org/library/papers/24780446 | PubMed |
| 7 | 32516126 | Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Aβ level in Porphyromonas gingivalis-infected mice. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32516126 | PubMed |
| 8 | 37904689 | Neuroprotective mechanism of salvianolic acid B against cerebral ischemia-reperfusion injury in mice through downregulation of TLR4, p-p38MAPK, p-JNK, NF-κB, and IL-1β. | Immun Inflamm Dis | 2023 | https://conductscience.org/library/papers/37904689 | PubMed |
| 9 | 16440326 | Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. | J Cell Biochem | 2006 | https://conductscience.org/library/papers/16440326 | PubMed |
| 10 | 26595643 | Vascular dementia. | Lancet | 2015 | https://conductscience.org/library/papers/26595643 | PubMed |
| 11 | 11742594 | Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro. | Acta Pharmacol Sin | 2001 | https://conductscience.org/library/papers/11742594 | PubMed |
| 12 | 39697159 | Interleukin-3 Modulates Macrophage Phagocytic Activity and Promotes Spinal Cord Injury Repair. | CNS Neurosci Ther | 2024 | https://conductscience.org/library/papers/39697159 | PubMed |
| 13 | 37708947 | The potential effect of salvianolic acid B against rat ischemic brain injury in combination with mesenchymal stem cells. | J Chem Neuroanat | 2023 | https://conductscience.org/library/papers/37708947 | PubMed |
| 14 | 37564636 | Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage. | Front Immunol | 2023 | https://conductscience.org/library/papers/37564636 | PubMed |
| 15 | 29551684 | Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29551684 | PubMed |
| 16 | 27258307 | Salvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells. | Nutrients | 2016 | https://conductscience.org/library/papers/27258307 | PubMed |
| 17 | 37913602 | Salvianolic acid B exerts protective effects against Aβ-induced neuroinflammation through the inhibition of NLRP3 inflammasome activation and switching of M1/M2 polarization. | Tissue Cell | 2023 | https://conductscience.org/library/papers/37913602 | PubMed |
| 18 | 29257241 | Salvianolic acid B recovers cognitive deficits and angiogenesis in a cerebral small vessel disease rat model via the STAT3/VEGF signaling pathway. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29257241 | PubMed |
| 19 | 22545124 | Direct stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid B. | PLoS One | 2012 | https://conductscience.org/library/papers/22545124 | PubMed |
| 20 | 29212498 | Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome. | J Neuroinflammation | 2017 | https://conductscience.org/library/papers/29212498 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42481908 | A Study on the Effects of Intranasally Administered Liquid Crystalline Nanoparticles Loaded with Salvianolic Acid B in Vascular Dementia. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42481908 | PubMed |
| 42191896 | T cell-targeted immunotherapies for multiple sclerosis: molecular mechanisms to therapeutic perspectives from Traditional Chinese medicine. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42191896 | PubMed |
| 42123431 | Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123431 | PubMed |
| 42004599 | The "habitat-phytochemistry-pharmacological effect" nexus: a multidimensional review of ethnomedicinal Salvia in China. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42004599 | PubMed |
| 41948424 | Potential correlation between chronic pain and amyloid beta in Alzheimer's disease. | Front Pain Res (Lausanne) | 2026 | https://conductscience.org/library/papers/41948424 | PubMed |
| 41788408 | Systems-level molecular and immunological evidence identifies Th17/Treg modulation as a key mechanism of CRSJ's neuroprotection in Parkinson's disease. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41788408 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40657643
GET https://conductscience.org/api/papers/v1/40657643/references?page=2